Publication date: October 2026 Source: Journal of Clinical Lipidology, Volume 20, Issue 10 Author(s): Sotirios Tsimikas, Erin Morgan, Jyoti Sharma, Tao Lin, Adam E. Mullick, Thazha P. Prakash, Eric E. Swayze, Thomas A. Prohaska
Single-dose ION775, a GalNAc-conjugated siRNA targeting APOC3, lowers triglycerides for up to 12 months in moderate hypertriglyceridemia. // Journal of Clinical Lipidology. – URL: https://www.sciencedirect.com/science/article/pii/S1933287426004836?dgcid=rss_sd_all
Single-dose ION775, a GalNAc-conjugated siRNA targeting APOC3, lowers triglycerides for up to 12 months in moderate hypertriglyceridemia. Journal of Clinical Lipidology. https://www.sciencedirect.com/science/article/pii/S1933287426004836?dgcid=rss_sd_all
“Single-dose ION775, a GalNAc-conjugated siRNA targeting APOC3, lowers triglycerides for up to 12 months in moderate hypertriglyceridemia.” Journal of Clinical Lipidology.
@article{article53090,
title = {Single-dose ION775, a GalNAc-conjugated siRNA targeting APOC3, lowers triglycerides for up to 12 months in moderate hypertriglyceridemia},
journal = {Journal of Clinical Lipidology},
url = {https://www.sciencedirect.com/science/article/pii/S1933287426004836?dgcid=rss_sd_all}
}